Affiliation:
1. The Affiliated Hospital of Yunnan University
2. Kunming Medical University
3. Chengdu Xi’nan Gynecology Hospital
Abstract
Abstract
Objective
To investigate the risk factors for clinical pregnancy in patients with recurrent embryo implantation failure (RIF) treated with in vitro fertilization-embryo transfer (IVF-ET) technique.
Methods
1074 patients treated with IVF-ET were matched for propensity score to reduce the effect of confounding factors. The final endometrial receptivity analysis (ERA) group and the conventional frozen embryo transfer (FET) group were each matched to 204 cases, with 201 in the failed pregnancy group and 207 in the successful pregnancy group. Their basic demographic characteristics and relevant clinical data were collected, and the Kaplan-Meier method was used to estimate the survival curves of the patients' pregnancy rates, and the factors influencing them were analysed using Cox regression models.
Results
The success and failure rates of clinical pregnancies in patients with RIF were 50.74% and 49.26%, respectively. Patients in the failed pregnancy group did not receive an ERA, had > 3 previous implantation failures, and were transferred with a single embryo, with no quality embryos transferred.
Conclusion
Not receiving an ERA, having > 3 previous implantation failures, using single embryo transfer and not transferring quality embryos are risk factors for clinical pregnancy in patients with RIF.
Publisher
Research Square Platform LLC
Reference27 articles.
1. Only women's age and the duration of infertility are the prognostic factors for the success rate of natural cycle IVF [J];Wolff M;Arch Gynecol Obstet,2019
2. Development and validation of an In-fertility Stigma Scale for Chinese women [;Fu B;J] J Psychosom ï¼²es,2015
3. The international glossary on infertility and fertility care;ZEGERS-HOCHSCHILD F, ADAMSON G D DYERS;2017 [J] Hum Reprod,2017
4. Study on the relationship between endocrine disorders and female infertility [J];Yang Xiaoli Y;China Maternal and Child Health Care,2019
5. Development and exploration of assisted reproductive technology [J];Yu Huijun H;Xinjiang Med,2019